Results 111 to 120 of about 486,420 (260)

Implementation of mass pharmacogenetic testing: Dihydropyrimidine dehydrogenase testing prior to fluoropyrimidine treatment for patients

British Journal of Clinical Pharmacology, EarlyView.
Aims Pharmacogenomics enables personalization of drug therapy improving effectiveness and/or safety. Dihydropyrimidine dehydrogenase [DPYD] testing prior to fluoropyrimidine chemotherapy was commissioned by NHS England in response to an update from the Medicines and Healthcare products Regulatory Agency.
Nisha Shaunak, Jessica Keen, Anna Kim, Munir Pirmohamed, William G. Newman, Paul J. Ross   +5 more
wiley   +1 more source

Barnes Hospital Bulletin [PDF]

, 1966
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1011/thumbnail ...

core   +1 more source

Implementing physician‐led medication reviews for patients with diabetes and severe mental disorder: A randomized controlled trial

British Journal of Clinical Pharmacology, EarlyView.
Aims Patients with severe mental disorder and diabetes may be exposed to inappropriate polypharmacy increasing the risk of side effects and drug interactions. Although medication reviews may facilitate short‐term deprescribing, they are not known to affect clinical outcomes.
Johan Frederik Mebus Meyer Christensen, Signe Wegmann Düring, Gesche Jürgens   +2 more
wiley   +1 more source

A single‐centre analysis of a biosimilar switching programme for adalimumab in inflammatory bowel disease

British Journal of Clinical Pharmacology, EarlyView.
Aims Amgevita is a licensed biosimilar to adalimumab, having demonstrated high pharmacokinetic and clinical similarity to Humira. Switching to a lower‐cost medicine may elicit a nocebo effect, whereby expectations of poorer efficacy impact outcomes despite pharmacological similarity. This prospective cohort study examined clinical and economic outcomes
Louise Rabbitt, Áine Keogh, Linda Duane, John Ferguson, Anna Hobbins, Brian E. McGuire, Patrick Gillespie, Laurence J. Egan   +7 more
wiley   +1 more source

Nurses\u27 Alumnae Association Bulletin - Volume 17 Number 1 [PDF]

, 1952
Alumnae Notes Committee Reports Digest of Alumnae Association Meetings Greetings from Miss Childs Greetings from the Educational Director Greetings from the President Graduation Awards - 1951 Jefferson\u27s New Hospital Addition Marriages Necrology ...
Alpers, Bernard J, Boerlin, Paully Jane, Childs, Katherine, Cozza, Angela R, Flack, Herbert L, Flanagan, Jeanne, Hamrick, Hayward R, Kevel, Isabelle, Kuba, Anna, Miller, Franklin R, Nentwig, Dorothy, Piersol, Betty, Plaisted, Marilyn, Skvir, Elsie, Spruance, Henrietta Fitzgerald, Whitney, Helen M, Yaeger, Rudolph, Zeldis, William   +17 more
core   +1 more source

Validity of the Medication Safety Self‐Assessment for Long‐Term Care tool in Australian long‐term care: a RAND appropriateness method study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aims The validity of using the Canadian Medication Safety Self‐Assessment for Long‐Term Care (MSSA‐LTC) tool in the international context is unknown. This study aims to determine the face and content validity of the Canadian MSSA‐LTC tool for assessing medication safety‐related processes in the Australian long‐term care (LTC) setting.
Ramesh Sharma Poudel, Sabrina J. M. Burer, Kylie A. Williams, Lisa G. Pont   +3 more
wiley   +1 more source

The 2024 Vasculitis Foundation Quality Care Summit: Seeking Strategies to Improve Care for All Patients

Arthritis &Rheumatology, EarlyView.
Jason Springer, Elizabeth Brant, Anisha Dua, Jason Wadler, Dahlia Mak, Peter Merkel, Beth Westbrook, Joyce Kullman, Kevin Byram   +8 more
wiley   +1 more source

The potential for clinical pharmacists to support older people with dementia in the community: A qualitative interview study

British Journal of Clinical Pharmacology, EarlyView.
Aims The prevalence of multiple long‐term health conditions including dementia is rising globally. Managing dementia presents significant challenges for healthcare providers. Clinical pharmacists, with expertise in medication management, have emerged as valuable members of the primary care team.
Alice Burnand, Abi Woodward, Kumud Kantilal, Cini Bhanu, Yogini Jani, Jill Manthorpe, Mine Orlu, Greta Rait, Madiha Sajid, Kritika Samsi, Victoria Vickerstaff, Jane Ward, Jane Wilcock, Nathan Davies   +13 more
wiley   +1 more source

Barnes Hospital Bulletin [PDF]

, 1967
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1018/thumbnail ...

core   +1 more source

Trends in drug–drug interaction prevalence and longitudinal associations with health outcomes in the older community‐dwelling population: Findings from The Irish LongituDinal study on Ageing

British Journal of Clinical Pharmacology, EarlyView.
Aims We estimate trends in severe drug–drug interaction (DDI) prevalence and examine longitudinal associations between DDI exposure and health outcomes (emergency department [ED] visits, quality‐of‐life [QoL] and functional decline) over approximately 10‐years in the older community‐dwelling population in Ireland.
John E. Hughes, Caitriona Cahir, Kathleen E. Bennett   +2 more
wiley   +1 more source